← Back to Search

Behavioural Intervention

CB-FAITH treatment for Depression (CB-FAITH Trial)

N/A
Waitlist Available
Led By Earlise Ward, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, weeks 6 and 12 during the intervention, and follow up at 3 and 6 months
Awards & highlights

CB-FAITH Trial Summary

This trial will test if a faith-based program can help reduce depression symptoms in African American adults in Wisconsin. Twelve church groups with 10 people each will be asked to join the study. If successful,

Who is the study for?
This trial is for African American adults in Wisconsin who are experiencing symptoms of depression. Participants will be part of church groups, with a total of 120 individuals across twelve groups being invited to join the study.Check my eligibility
What is being tested?
The study is testing 'Cognitive Behavioral Faith Fellowship to Improve Thy Health (CB-FAITH)', which is a faith-based intervention aimed at reducing depression symptoms. It's designed specifically for African Americans and could become the first evidence-based program of its kind if successful.See study design
What are the potential side effects?
Since this trial involves cognitive behavioral therapy within a faith fellowship context, typical medical side effects are not expected. However, participants may experience emotional discomfort or distress as they engage with their depressive symptoms during therapy.

CB-FAITH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, weeks 6 and 12 during the intervention, and follow up at 3 and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, weeks 6 and 12 during the intervention, and follow up at 3 and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Health Questionnaire
Score on Quick Inventory of Depressive Symptomatology-clinician rated (QIDS-CR)
Secondary outcome measures
Client Satisfaction Inventory (CSI) score
Multidimensional Measure of Religious Involvement (MMRI) score

CB-FAITH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CB-FAITH treatmentExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,167,267 Total Patients Enrolled
22 Trials studying Depression
10,165 Patients Enrolled for Depression
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,822,228 Total Patients Enrolled
17 Trials studying Depression
12,793 Patients Enrolled for Depression
Earlise Ward, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
121 Total Patients Enrolled
2 Trials studying Depression
121 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are potential participants currently able to apply for enrollment in this ongoing clinical trial?

"As per the details on clinicaltrials.gov, it appears that recruitment for this particular trial is currently paused. The trial was initially listed on April 1st, 2024, with the latest update made on February 27th, 2024. Despite this study not accepting participants presently, there are approximately 1254 other ongoing trials actively seeking volunteers at this time."

Answered by AI
~80 spots leftby Sep 2026